J. Yang, D. Poch, M. Bautista, T. Fernandes, K. Kerr, D. Papamatheakis, V. Pretorius, M. Madani, M. Patel, E. Mahmud, N. Kim
{"title":"在大容量肺血栓动脉内膜切除术中心行球囊肺血管成形术患者的特点:美国单中心经验","authors":"J. Yang, D. Poch, M. Bautista, T. Fernandes, K. Kerr, D. Papamatheakis, V. Pretorius, M. Madani, M. Patel, E. Mahmud, N. Kim","doi":"10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a4911","DOIUrl":null,"url":null,"abstract":"Chronic thromboembolic pulmonary hypertension (CTEPH) is the result of incompletely resolved pulmonary emboli (PE) that lead to chronic right heart failure. The two mechanical treatment options are pulmonary thromboendar-terectomy (PTE) and balloon pulmonary angioplasty (BPA). There are no formal criteria for BPA patient selection and treatment decisions vary according to a center's experience with BPA and PTE. We performed a retrospective review of consecutive patients treated with PTE and BPA at UCSD from March 2015 to 2021. Clinical and hemodynamic data were collected. Patients were categorized according to the rationale for BPA. One hundred fifty three patients underwent 643 BPA sessions, and 1104 patients underwent PTE. Patients selected for PTE had worse baseline hemodynamics with mean pulmonary artery pressure 41.1 ± 11.7 versus 34.6 ± 11.2 mmHg, p < 0.001. 59% of patients selected for BPA had surgically inaccessible disease","PeriodicalId":286050,"journal":{"name":"C105. CIVIC CENTER: PULMONARY VASCULAR DISEASE","volume":"4 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Characteristics of Patients Treated with Balloon Pulmonary Angioplasty at a High-Volume Pulmonary Thromboendarterectomy Center: Single Center USA Experience\",\"authors\":\"J. Yang, D. Poch, M. Bautista, T. Fernandes, K. Kerr, D. Papamatheakis, V. Pretorius, M. Madani, M. Patel, E. Mahmud, N. Kim\",\"doi\":\"10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a4911\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Chronic thromboembolic pulmonary hypertension (CTEPH) is the result of incompletely resolved pulmonary emboli (PE) that lead to chronic right heart failure. The two mechanical treatment options are pulmonary thromboendar-terectomy (PTE) and balloon pulmonary angioplasty (BPA). There are no formal criteria for BPA patient selection and treatment decisions vary according to a center's experience with BPA and PTE. We performed a retrospective review of consecutive patients treated with PTE and BPA at UCSD from March 2015 to 2021. Clinical and hemodynamic data were collected. Patients were categorized according to the rationale for BPA. One hundred fifty three patients underwent 643 BPA sessions, and 1104 patients underwent PTE. Patients selected for PTE had worse baseline hemodynamics with mean pulmonary artery pressure 41.1 ± 11.7 versus 34.6 ± 11.2 mmHg, p < 0.001. 59% of patients selected for BPA had surgically inaccessible disease\",\"PeriodicalId\":286050,\"journal\":{\"name\":\"C105. CIVIC CENTER: PULMONARY VASCULAR DISEASE\",\"volume\":\"4 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"C105. CIVIC CENTER: PULMONARY VASCULAR DISEASE\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a4911\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"C105. CIVIC CENTER: PULMONARY VASCULAR DISEASE","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a4911","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
慢性血栓栓塞性肺动脉高压(CTEPH)是不完全溶解的肺栓塞(PE)导致慢性右心衰的结果。两种机械治疗选择是肺血栓腔内膜切除术(PTE)和球囊肺血管成形术(BPA)。BPA患者的选择并没有正式的标准，治疗决定也会根据中心对BPA和PTE的经验而有所不同。我们对2015年3月至2021年在加州大学圣地亚哥分校连续接受PTE和BPA治疗的患者进行了回顾性研究。收集临床和血流动力学资料。根据BPA的基本原理对患者进行分类。153例患者接受了643次BPA治疗，1104例患者接受了PTE治疗。PTE患者的基线血流动力学更差，平均肺动脉压为41.1±11.7比34.6±11.2 mmHg, p < 0.001。选择BPA的患者中有59%患有手术无法触及的疾病
Characteristics of Patients Treated with Balloon Pulmonary Angioplasty at a High-Volume Pulmonary Thromboendarterectomy Center: Single Center USA Experience
Chronic thromboembolic pulmonary hypertension (CTEPH) is the result of incompletely resolved pulmonary emboli (PE) that lead to chronic right heart failure. The two mechanical treatment options are pulmonary thromboendar-terectomy (PTE) and balloon pulmonary angioplasty (BPA). There are no formal criteria for BPA patient selection and treatment decisions vary according to a center's experience with BPA and PTE. We performed a retrospective review of consecutive patients treated with PTE and BPA at UCSD from March 2015 to 2021. Clinical and hemodynamic data were collected. Patients were categorized according to the rationale for BPA. One hundred fifty three patients underwent 643 BPA sessions, and 1104 patients underwent PTE. Patients selected for PTE had worse baseline hemodynamics with mean pulmonary artery pressure 41.1 ± 11.7 versus 34.6 ± 11.2 mmHg, p < 0.001. 59% of patients selected for BPA had surgically inaccessible disease
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
